Clinical Trial Update: A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 study of LY4213663 in healthy participants and rheumatoid arthritis patients is currently recruiting. Sponsor is Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• LY4213663

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Rheumatoid Arthritis (RA) | Phase 1 | Status: RECRUITING